“You will have proven experience at coaching and developing teams and supporting individuals to grow and thrive.”
Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study
The hallmark of sickle cell disease (SCD) is vaso-occlusive pain that may be acute and episodic or may progress to chronic, persistent pain with unpredictable and disabling exacerbations. Patients with SCD rely on opioids almost exclusively for acute and chronic pain management. Participants described increased stigmatization about opioid use and that their medical care was being affected by the physician’s exclusive focus on reducing pain medication use. There was an emerging interest among adult patients in the consideration of the use of alternative therapies, including marijuana, to manage pain.
The TSA began work on updating their cannabis policy last year, when the FDA approved the cannabis-based anti-seizure medication Epidiolex.
The bill would give veterinarians the same protections as doctors who recommend marijuana for human patients.